P-128 is under clinical development by GangaGen Biotechnologies and currently in Phase II for Staphylococcus aureus Infections.

These include cationic antimicrobial peptides, S100 family proteins, peptidoglycan-recognition proteins (PGRPs in invertebrates, PGLYRPs in vertebrates), calcium-dependent lectins (C-type lectins ...

HY-133 is under clinical development by HyPharm and currently in Phase I for Staphylococcal Infections. According to GlobalData, Phase I drugs for Staphylococcal Infections have a 63% phase transition ...

eLife is a non-profit organisation inspired by research funders and led by scientists. Our mission is to help scientists accelerate discovery by operating a platform for research communication that ...

Renal Blood urea nitrogen or creatinine at least twice the upper limit of normal for laboratory or urinary sediment with pyuria (≥5 leukocytes per high-power field) in the absence of urinary ...

Oral metronidazole and vancomycin have been compared to determine if one agent is more efficacious than the other. A prospective, randomized, controlled clinical trial compared metronidazole 250 ...

Department of Chemistry, Indiana University, 800 E. Kirkwood Avenue, Bloomington, Indiana 47405, United States ...